Navigation Links
Preventing physician medication mix-ups by reporting them
Date:12/3/2010

INDIANAPOLIS The most frequent contributors to medication errors and adverse drug events in busy primary care practice offices are communication problems and lack of knowledge, according to a study of a prototype web-based medication error and adverse drug event reporting system.

Research on the use of MEADERS (Medication Error and Adverse Drug Event Reporting System), developed by investigators from the Regenstrief Institute and Indiana University School of Medicine led by Atif Zafar, M.D., appears in the November/December 2010 issue of the Annals of Family Medicine.

"We as physicians have a responsibility to make good decisions and to translate those decisions into safe and effective care. If we make a mistake we need to learn from the mistake and prevent it from reoccurring. We found this first generation reporting system to be popular with physicians and others in their offices, in spite of time pressures and a culture that does not support admitting mistakes," said William M. Tierney, M.D., president and CEO of the Regenstrief Institute. Dr. Tierney, who is also associate dean for clinical effectiveness research at the IU School of Medicine, is a co-developer of MEADERS and is the senior author of the Annals of Family Medicine study.

Urban, suburban and rural primary care practices in California, Connecticut, Oregon and Texas used MEADERS for 10 weeks, submitting 507 confidential event reports. The average time spent reporting an event was a little over four minutes. Seventy percent of reports included medication errors only. Only two percent included both medication errors and adverse drug events.

"Our study has created what is now the largest database of medication errors in primary care," said Dr. Tierney. "It taught us many real world lessons that we are applying to the next generation reporting system currently under development. It also informed the practices of problems encountered by the doctors, practices and patients in the safe and effective use of drugs. Only by uncovering such problems can they be dealt with to prevent future events. MEADERS allowed a safe and secure means whereby the practices can report such problems."

Medications used for cardiovascular, central nervous system (including pain killers), endocrine diseases (mainly diabetes), and antibiotics were most often associated with the events reported in MEADERS.

Medication errors were equally divided among ordering medications, implementing prescription orders, errors by patients receiving the medications and documentation errors. There was no harm in two-thirds of the patients, documented harm in 11 percent, and nothing mentioned for 20 percent.

"We demonstrated that it is feasible to deploy a web-based medication event reporting system that clinicians and staff can understand and use in busy primary care practices. The real challenge is to demonstrate that event reporting is sustainable and that the data from event reporting can be used in an ongoing way to identify and to correct systems problems to reduce medication errors, adverse drug events, hospital admissions and patient harm," said Dr. Tierney.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert

Related medicine news :

1. Lifestyle Key to Preventing Stroke, Guidelines Say
2. Celecoxib may be effective in preventing non-melanoma skin cancers
3. Celebrex Shows Potential in Preventing Some Skin Cancers: Study
4. Pitt study finds NSAIDs cause stem cells to self-destruct, preventing colon cancer
5. New clinical trial explores role of vitamin D in preventing esophageal cancer
6. UCI gets major funding to study ways of preventing drug-resistant staph infections
7. Studies offer encouraging data on preventing Crohns disease recurrence
8. Circumcising gay men would have limited impact on preventing HIV
9. The Rubit Dog Tag Clips Making Big Pet Store Sales, Everyday Dog Ownership Easier, Preventing Broken Fingernails.
10. Dual Therapy Best for Preventing Bleeding After Heart Procedures
11. Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... -centric training, today announced the launch of a new research study, The Business ... skills needed to execute that strategy, and the actual success of achieving individual ...
(Date:3/27/2017)... ... , ... According to the American Cancer Society , the average 15-year ... Once the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year ... this latter group, tune in to Lifestyle Magazine on April 9, 2017, ...
(Date:3/27/2017)... ... 2017 , ... Golden Triangle Emergency Center will be hosting ... to commemorate the two-year anniversary of the facility. The event will feature refreshments ... years while also familiarizing themselves with the facility. , In the two years ...
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease ... hospitals in the United States, it’s a threat that is constantly changing and ... infection prevention and offers strategies for the healthcare community to help decrease the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: